At the time of writing, Zimmer Biomet Holdings Inc [ZBH] stock is trading at $107.32, down -0.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZBH shares have gain 4.64% over the last week, with a monthly amount glided 10.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on July 15, 2025, when Roth Capital upgraded its rating to a Buy but kept the price target unchanged to $135 for it. Previously, JP Morgan upgraded its rating to Overweight on December 17, 2024, and elevated its price target to $128. On September 10, 2024, Wolfe Research initiated with a Peer Perform rating. Piper Sandler downgraded its rating to a Neutral and decreased its price target to $115 on July 01, 2024. Goldman initiated its recommendation with a Neutral and recommended $129 as its price target on May 30, 2024. Argus upgraded its rating to Buy for this stock on May 21, 2024, but kept the price target unchanged to $150. In a note dated January 04, 2024, Evercore ISI downgraded an In-line rating on this stock and revised its target price from $135 to $125.
For the past year, the stock price of Zimmer Biomet Holdings Inc fluctuated between $89.22 and $116.71. Currently, Wall Street analysts expect the stock to reach $104.4 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $107.32 at the most recent close of the market. An investor can expect a potential drop of -2.72% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
According to Zimmer Biomet Holdings Inc [NYSE:ZBH], the company’s sales were 7.83B for trailing twelve months, which represents an 6.97% jump. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 106.56 points at the first support level, and at 105.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 108.16, and for the 2nd resistance point, it is at 108.99.
Ratios To Look Out For
It is important to note that Zimmer Biomet Holdings Inc [NYSE:ZBH] has a current ratio of 1.87. Further, the Quick Ratio stands at 0.96, while the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 2.71, the price to book ratio is 1.70 and price to earnings (TTM) ratio is 26.13.
Transactions by insiders
Recent insider trading involved Winkler Lori, SVP and CHRO, that happened on Aug 18 ’25 when 1500.0 shares were sold. Officer, Bezjak Mark completed a deal on Aug 13 ’25 to buy 7500.0 shares. Meanwhile, Group President, Asia Pacific Yi Sang sold 800.0 shares on Jun 13 ’25.
